Nanjing
688105.SSNanjing Vazyme Biotech Co., Ltd. Price (688105.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
394,201,330
(1.4521)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | 112,372,334 | 170,804,715 | 268,380,113 | 1,564,454,261 | 1,868,627,293 | 3,568,984,515 | 1,285,988,243 |
| Net Income | 3,644,557 | 1,038,712 | 25,794,825 | 821,725,047 | 678,289,569 | 594,245,543 | -70,956,239 |
| FCF USD | -22,680,920 | -36,131,966 | -4,679,258 | 651,010,148 | 354,840,675 | -227,694,524 | -79,913,179 |
| OCF USD | -3,860,196 | -3,999,178 | 15,202,384 | 803,552,650 | 616,800,880 | 735,165,884 | 152,987,968 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.22 | -1.51 |
| D/E | 0.04 | 0.19 | 0.18 | 0.00 | 0.02 | 0.10 | 0.32 |
| CA/CL | 4.00 | 2.19 | 2.14 | 5.83 | 10.46 | 3.96 | 2.78 |
| TA/TL | 5.01 | 2.96 | 2.61 | 5.77 | 9.60 | 4.31 | 3.35 |
| Total Debt | 5,543,766 | 31,160,000 | 35,688,809 | 1,150,773 | 91,182,177 | 458,140,400 | 1,287,017,222 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| ROIC | 2.31% | 0.65% | 10.23% | 60.25% | 16.10% | 22.78% | -1.17% |
| ROE | 2.42% | 0.63% | 12.90% | 61.67% | 16.43% | 12.89% | -1.76% |
| ROA | 0.00% | 0.41% | 7.95% | 50.99% | 14.72% | 9.88% | -1.23% |
| NM % | 3.24% | 0.61% | 9.61% | 52.52% | 36.30% | 16.65% | -5.52% |
| FCF / R% | 0.00% | -21.15% | -1.74% | 41.61% | 18.99% | -6.38% | -6.21% |
| FCF / NI% | -622.32% | -3,478.54% | -18.14% | 79.22% | 52.31% | -38.36% | 112.62% |
| Operating Margin (OM) | 0.00 | -0.21 | -0.06 | 0.37 | 0.64 | 0.44 | 0.78 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| EPS | 0.01 | 0.00 | 0.06 | 2.05 | 1.70 | 1.49 | -0.18 |
| SPS | 0.32 | 0.48 | 0.67 | 3.91 | 4.67 | 8.92 | 3.26 |
| OCPS | -0.01 | -0.01 | 0.04 | 2.01 | 1.54 | 1.84 | 0.39 |
| FCPS | -0.06 | -0.10 | -0.01 | 1.63 | 0.89 | -0.57 | -0.20 |
| BVPS | 0.42 | 0.47 | 0.50 | 3.33 | 10.32 | 11.53 | 10.22 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.01 | 0.00 | 0.06 | 2.05 | 1.70 | 1.49 | -0.18 |
| CAGR-SPS | 0.32 | 0.48 | 0.67 | 3.91 | 4.67 | 8.92 | 3.26 |
| CAGR-OCPS | -0.01 | -0.01 | 0.04 | 2.01 | 1.54 | 1.84 | 0.39 |
| CAGR-FCPS | -0.06 | -0.10 | -0.01 | 1.63 | 0.89 | -0.57 | -0.20 |
| CAGR-BVPS | 0.42 | 0.47 | 0.50 | 3.33 | 10.32 | 11.53 | 10.22 |